Relevance of the colloidal stability of chitosan/PLGA nanoparticles on their cytotoxicity profile

International Journal of Pharmaceutics

Volumn 381, Issue 2, 2009, Pages 130-139

  Nafee, Noha ^a   Schneider, Marc ^a   Schaefer, Ulrich F ^a   Lehr, Claus Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Chitosan; Colloidal properties; Cytotoxicity; In vitro tests; LDH assay; MTT assay; PLGA nanoparticles

Indexed keywords

CHITOSAN; NANOPARTICLE; POLYGLACTIN;

ACIDITY; ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; COLLOID; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; HUMAN; HUMAN CELL; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; SCANNING FORCE MICROSCOPY; SURFACE CHARGE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE; CELL SURVIVAL; CHITOSAN; COLLOIDS; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG STABILITY; ELECTRIC IMPEDANCE; ELECTROCHEMICAL TECHNIQUES; GLYCOLATES; HUMANS; HYDROGEN-ION CONCENTRATION; MATERIALS TESTING; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PARTICLE SIZE; SERUM; SURFACE PROPERTIES;

EID: 70349279929     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.04.049     Document Type: Article

References (33)

1. Agnihotri S.A., Mallikarjuna N.N., and Aminabhavi T.M. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J. Control. Release 100 (2004) 5-28
2. Amidi M., Romeijn S.G., Verhoef J.C., Junginger H.E., Bungener L., Huckriede A., Crommelin D.J.A., and Jiskoot W. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model. Vaccine 25 (2007) 144-153
3. Azarmi S., Roa W.H., and Löbenberg R. Targeted delivery of nanoparticles for the treatment of lung diseases. Adv. Drug Deliv. Rev. 60 (2008) 863-875
4. Barrett D.A., Hartshorne M.S., Hussain M.A., Shaw P.N., and Davies M.C. Resistance to nonspecific protein adsorption by poly(vinyl alcohol) thin films adsorbed to a poly(styrene) support matrix studied using surface plasmon resonance. Anal. Chem. 73 (2001) 5232-5239
5. Carreno-Gomez B., and Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int. J. Pharm. 148 (1997) 231-240
6. Choksakulnimitr S., Masuda S., Tokuda H., Takakura Y., and Hashida M. In vitro cytotoxicity of macromolecules in different cell culture systems. J. Control. Release 34 (1995) 233-241
7. Corsi K., Chellat F., Yahia L., and Fernandes J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials 24 (2003) 1255-1264
8. Dodane V., Amin Khan M., and Merwin J.R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 182 (1999) 21-32
9. Ferruti P., Knobloch S., Ranucci E., Gianasi E., and Duncan R. A novel chemical modification of poly-l-lysine reducing toxicity while preserving cationic properties. Proc. Int. Symp. Control. Rel. Bioact. Mater. 24 (1997) 45-46
10. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., and Kissel T. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24 (2003) 1121-1131
11. Fischer H.C., and Chan W.C.W. Nanotoxicity: the growing need for in vivo study. Curr. Opin. Biotechnol. 18 (2007) 565-571
12. Guggi D., Langoth N., Hoffer M.H., Wirth M., and Bernkop-Schnürch A. Comparative evaluation of cytotoxicity of a glucosamine-TBA conjugate and a chitosan -TBA conjugate. Int J. Pharm 278 (2004) 353-360
13. Hohne S., Frenzel R., Heppe A., and Simon F. Hydrophobic chitosan microparticles: heterogeneous phase reaction of chitosan with hydrophobic carbonyl reagents. Biomacromolecules (2007)
14. Hwang H., Kim I.-S., Kwon I.C., and Kim Y.-H. Tumor targetability and antitumor effect of docetaxel loaded hydrophobically modified glycol chitosan nanoparticles. J. Control. Release 128 (2008) 23-31
15. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 15 (1998) 1326-1331
16. Issa M.M., Koping-Hoggard M., and Artursson P. Chitosan and the mucosal delivery of biotechnology drugs. Drug Discov. Today: Technol. 2 (2005) 1-6
17. Jin S., and Ye K. Nanoparticle-mediated drug delivery and gene therapy. Biotechnol. Prog. 23 (2007) 32-41
18. Kean T., Roth S., and Thanou M. Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. J. Control. Release 103 (2005) 643-653
19. Lee M., Nah J.W., Kwon Y., Koh J.J., Ko K.S., and Kim S.W. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 18 (2001) 427-431
20. Lv H., Zhang S., Wang B., Cui S., and Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release 114 (2006) 100-109
21. Martien R., Loretz B., Thaler M., Majzoob S., and Bernkop-Schnürch A. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?. J. Biomed. Mater. Res. 82A (2007) 1-9
22. Mueller H., Kassack M.U., and Wiese M. Comparison of the usefulness of the MTT, ATP, and calcein assays to predict the potency of cytotoxic agents in various human cancer cell lines. J. Biomol. Screen. 9 (2004) 506-515
23. Nafee N., Taetz S., Schneider M., Schaefer U.F., and Lehr C.M. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nanomed. Nanotechnol. Biol. Med. 3 (2007) 173-183
24. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev.: Biomed. Micro- Nano-Technol. 55 (2003) 329-347
25. Qi L., Xu Z., Jiang X., Li Y., and Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg. Med. Chem. Lett. 15 (2005) 1397-1399
26. Ravi Kumar M.N.V., Bakowsky U., and Lehr C.M. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 25 (2004) 1771-1777
27. Richardson S.C.W., Kolbe H.V.J., and Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178 (1999) 231-243
28. Schulze C., Kroll A., Lehr C.-M., Schäfer U.F., Becker K., Schnekenburger J.r., Schulze Isfort C., Landsiedel R., and Wohlleben W. Not ready to use-overcoming pitfalls when dispersing nanoparticles in physiological media. Nanotoxicology 2 (2008) 51-61
29. Singh A., Kasinath B., and Lewis E. Interaction of polycations with cell-surface negative charges of epithelial cells. Biochim. Biophys. Acta 1120 (1992) 337-342
30. Smith J., Wood E., and Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 21 (2004) 43-49
31. Taetz S., Nafee N., Beisner J., Piotrowska K., Baldes C., Mürdter T.E., Huwer H., Schneider M., Schaefer U.F., Klotz U., and Lehr C.-M. The influence of chitosan content in cationic chitosan/PLGA nanoparticles on the delivery efficiency of antisense 2′-O-methyl-RNA directed against telomerase in lung cancer cells. Eur. J. Pharm. Biopharm. 72 (2009) 358-369
32. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., and Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 6 (2006) 1794-1807
33. Yin H., Too H.P., and Chow G.M. The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26 (2005) 5818-5826